Ask about this productRelated genes to: ANXA10 antibody
- Gene:
- ANXA10 NIH gene
- Name:
- annexin A10
- Previous symbol:
- -
- Synonyms:
- ANX14
- Chromosome:
- 4q32.3
- Locus Type:
- gene with protein product
- Date approved:
- 1999-09-17
- Date modifiied:
- 2014-11-18
Related products to: ANXA10 antibody
Related articles to: ANXA10 antibody
- Circulating proteins act as important hormonal signals of nutrient intake. We aimed to systematically characterise the time-resolved proteomic response to glucose ingestion in humans, and to assess its robustness following prolonged complete caloric restriction. - Source: PubMed
Publication date: 2026/07/17
Uluvar BurulçaWilliamson AliceKolnes Kristoffer JJeppesen Per BendixKolnes Anders JKoprulu MineZoodsma MartijnBeuchel CarlBambal YankiReines MarYasmeen SummairaMaj CarloSchumacher JohannesO'Rahilly Stephenvan Heel David ABartfeld SinaCarrasco-Zanini JuliaJensen JørgenPietzner MaikLangenberg Claudia - Gastric cancer (GC) exhibits marked epidemiological differences between European (EUR) and East Asian (EAS) populations, with significantly higher incidence rates in EAS. Circulating proteins represent promising drug targets; however, most proteomic studies have focused primarily on EUR ancestry, leaving EAS-specific targets largely underexplored. This study aims to identify ancestry-specific plasma protein targets for GC using Mendelian randomization (MR). - Source: PubMed
Publication date: 2026/05/01
Zhi PengCui YanXue GuanghuiQiao LingyuGeng JieChang ZhengyaoXu YinmeiYan JuanjuanWang YingliZhao Chenghui - Esophageal squamous cell carcinoma (ESCC) significantly impacts public health. Variability exists in patients' responses to chemoradiotherapy (CRT), and the role of purinergic signaling (PS) in ESCC, related to tumor migration, remains unclear. - Source: PubMed
Publication date: 2026/03/17
Zhan XiangZhou FenggeYang YuanhuiLei LingliLi MiaoLi JixianFeng AleiQu YanZeng RenyaYang Zhe - Trastuzumab is the first-line therapy for human epidermal growth factor receptor-2 (HER2)-positive gastric cancer (GC). However, intrinsic and acquired resistance due to hyperactivation of intracellular signaling pathway such as MEK/ERK pathways limit its clinical benefits. Plant-derived bioactive compounds have emerged as promising candidates to overcome trastuzumab resistance due to their multi-target effects and favorable safety profiles. - Source: PubMed
Publication date: 2026/03/02
Zhao HuimingYang JumeiYu HongweiLiu HaotianHe QichenLi ZhengyangPan FeifeiWu LeleShi WenguiJiao Zuoyi - The lack of specific and immunocompetent gastric cancer models has hindered the exploration of gastric adenocarcinoma (GAC). We constructed a spontaneous and transplantable GAC model using a genetically engineered mouse. - Source: PubMed
Publication date: 2026/02/03
Madeti YelizhatiChong XiaoyiZhang Xiaotian